| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10213514 | International Journal of Cardiology | 2018 | 34 Pages |
Abstract
This systematic literature review of NMAs showed varying levels of bleeding risk among DOACs, with apixaban generally having a lower risk than rivaroxaban and dabigatran 150â¯mg.
Keywords
NVAFDOACPICOSPRISMARCTRandomized controlled trialSystemic embolismPreferred Reporting Items for Systematic Reviews and Meta-AnalysesEfficacyRandomized Evaluation of Long-Term Anticoagulation TherapySafetySystematic literature reviewRE-LYGastrointestinalDirect oral anticoagulantDirect oral anticoagulantsAtrial fibrillationNonvalvular atrial fibrillationRisk ratiohazard ratioodds ratio
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A.T. Cohen, N.R. Hill, X. Luo, C. Masseria, S.A. Abariga, A.O. Ashaye,